These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38191429)

  • 1. A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients.
    de Araujo FM; Comim FV; Lamounier RN; Pena NF; Fajardo VC; de Faria RBG; Silva YM; Lauria MW
    Diabetol Metab Syndr; 2024 Jan; 16(1):10. PubMed ID: 38191429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.
    Tecce N; Masulli M; Lupoli R; Della Pepa G; Bozzetto L; Palmisano L; Rivellese AA; Riccardi G; Capaldo B
    Cardiovasc Diabetol; 2020 Oct; 19(1):166. PubMed ID: 33010807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes.
    Goh YA; Lan NSR; Linn K; Wood C; Gupta A; Yeap BB; Fegan PG
    J Diabetes Complications; 2023 Aug; 37(8):108557. PubMed ID: 37473636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM.
    Llauradó G; Cano A; Albert L; Ballesta S; Mazarico I; Luchtenberg MF; González-Sastre M; Megía A; Simó R; Vendrell J; González-Clemente JM
    PLoS One; 2019; 14(9):e0220206. PubMed ID: 31483791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study.
    Tecce N; Masulli M; Palmisano L; Gianfrancesco S; Piccolo R; Pacella D; Bozzetto L; Massimino E; Della Pepa G; Lupoli R; Vaccaro O; Riccardi G; Capaldo B
    Diabetes Res Clin Pract; 2022 Aug; 190():110001. PubMed ID: 35863552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Insulin Resistance in Estimating Cardiovascular Risk in Subjects with Type 1 Diabetes According to the Scores of the Steno Type 1 Risk Engine.
    Cano A; Llauradó G; Albert L; Mazarico I; Astiarraga B; González-Sastre M; Martínez L; Fernández-Veledo S; Simó R; Vendrell J; González-Clemente JM
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32664522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine.
    Vistisen D; Andersen GS; Hansen CS; Hulman A; Henriksen JE; Bech-Nielsen H; Jørgensen ME
    Circulation; 2016 Mar; 133(11):1058-66. PubMed ID: 26888765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools.
    Helleputte S; Van Bortel L; Verbeke F; Op 't Roodt J; Calders P; Lapauw B; De Backer T
    Cardiovasc Diabetol; 2022 Jun; 21(1):97. PubMed ID: 35681143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
    Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
    Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.
    Asghar S; Asghar S; Shahid S; Fatima M; Bukhari SMH; Nadeem Siddiqui S
    Cureus; 2023 May; 15(5):e39076. PubMed ID: 37323312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
    Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study.
    Jensen MT; Sogaard P; Andersen HU; Bech J; Fritz Hansen T; Biering-Sørensen T; Jørgensen PG; Galatius S; Madsen JK; Rossing P; Jensen JS
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):400-410. PubMed ID: 25746329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.